Medindia LOGIN REGISTER
Medindia
Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization

Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization - References


References:

  1. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 - (https://jamanetwork.com/journals/jama/fullarticle/2773108)
  2. Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19 - (https://academic.oup.com/ofid/article/8/2/ofab050/6124100)
  3. OCD drug spotlighted as potential COVID-19 treatment - (https://www.cidrap.umn.edu/news-perspective/2021/04/ocd-drug-spotlighted-potential-covid-19-treatment)
  4. What Is Fluvoxamine? OCD Drug Could Be Used to Treat COVID - (https://www.newsweek.com/covid-treatment-fluvoxamine-explained-disease-clinical-trials-1574467)
Author: Karishma Abhishek

Editor: Dr. Sunil Shroff

Technical: Radhika
Advertisement